1. Medtech Insight

Exec Chat: Dexcom’s CEO On Meeting New CGM Markets While Scoping Consumer Opportunities

 
• By Marion Webb

In this first of a series of Exec Chats with leaders at major diabetes companies presenting at ADA’s Scientific Sessions 2023, CEO Kevin Sayer discusses Dexcom’s ambitious R&D map to expand into metabolic health and develop innovative new products for diabetes and consumer markets.

American Diabetes Association Annual Meeting 2023: San Diego, California, USA - January 29, 2018: A panoramic morning view of San Diego Marina, surrounded by modern high-rising buildings, at side of San Diego Bay in Marina District of the Downtown.
• Source: Shutterstock

DexCom, Inc. kicked off the American Diabetes Association (ADA) on a bullish note.

The San Diego-based leader in continuous glucose monitoring raised its 2025 revenue targets by $600m to a range of $4

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business